These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2407469)

  • 21. Pharmacologic manipulation of the respiratory control center in the infant.
    Locke RG; Salvia JV
    J Am Osteopath Assoc; 1990 Jul; 90(7):602-4, 607-12. PubMed ID: 2198244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Theophylline therapy in obstructive respiratory diseases. 2. Theophyllin-retard preparations for the long-term treatment of non-smokers with or without cardiac insufficiency (author's transl)].
    Wemhöner S; Oellerich M; Sybrecht G
    Prax Klin Pneumol; 1981 Jan; 35(1):42-6. PubMed ID: 6782562
    [No Abstract]   [Full Text] [Related]  

  • 23. [Importance of the association of a salidiuretic and a theophylline derivative in the treatment of obesity with respiratory insufficiency].
    Vague J; Miller G; Teitelbaum M
    Sem Ther; 1965 May; 41(5):309-10. PubMed ID: 5878951
    [No Abstract]   [Full Text] [Related]  

  • 24. Steroid-induced change in the respiratory muscles: its relevance in patients with obstructive airways disease.
    Dekhuijzen PN; van Balkom RH
    Respir Med; 1994 May; 88(5):335-41. PubMed ID: 8036301
    [No Abstract]   [Full Text] [Related]  

  • 25. Aminophylline and the respiratory muscles: an alternative view.
    Moxham J
    Clin Chest Med; 1988 Jun; 9(2):325-36. PubMed ID: 3292131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Principles of theophylline therapy in obstructive respiratory diseases].
    Ukena D; Sybrecht GW
    Pneumologie; 1992 Feb; 46(2):49-51. PubMed ID: 1549553
    [No Abstract]   [Full Text] [Related]  

  • 27. [The value of theophylline therapy in the treatment of obstructive respiratory tract diseases].
    Kublik A; von Wichert P
    Internist (Berl); 1988 Nov; 29(11):727-33. PubMed ID: 3069786
    [No Abstract]   [Full Text] [Related]  

  • 28. [Theophylline therapy in obstructive respiratory diseases. 1. Bioavailability and pharmacokinetics of various theophylline preparations (author's transl)].
    Wemhöner S; Oellerich M; Sybrecht G
    Prax Klin Pneumol; 1981 Jan; 35(1):36-41. PubMed ID: 7208408
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinico-pharmacologic aspects of prescribing theophylline-containing preparations].
    Staib AH; Rietbrock N
    Prax Klin Pneumol; 1985 Aug; 39(8):276-80. PubMed ID: 4034490
    [No Abstract]   [Full Text] [Related]  

  • 30. [Optimizing of therapy with theophylline preparations in obstructive respiratory diseases. 4. Effect of theophylline on mucociliary clearance and maximal inspiratory mouth occlusion pressure].
    Schmidt G; Ranke C; Creutzig H; Oellerich M; Sybrecht GW
    Prax Klin Pneumol; 1983 Apr; 37(4):154-60. PubMed ID: 6866926
    [No Abstract]   [Full Text] [Related]  

  • 31. Does corticosteroid treatment affect the respiratory muscles?
    Dekhuijzen PN; Gayan-Ramirez G; Decramer M
    Eur Respir J; 1993 Apr; 6(4):465-6. PubMed ID: 8491294
    [No Abstract]   [Full Text] [Related]  

  • 32. Respiratory steroid myopathy.
    Gallagher CG
    Am J Respir Crit Care Med; 1994 Jul; 150(1):4-6. PubMed ID: 8025769
    [No Abstract]   [Full Text] [Related]  

  • 33. Respiratory muscle pharmacology.
    Decramer M
    Monaldi Arch Chest Dis; 1996 Dec; 51(6):499-503. PubMed ID: 9046162
    [No Abstract]   [Full Text] [Related]  

  • 34. [Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases].
    Rabe KF; Dent G; Magnussen H
    Pneumologie; 1997 Mar; 51(3):303-16. PubMed ID: 9173421
    [No Abstract]   [Full Text] [Related]  

  • 35. Indications for beta-adrenergic drugs in the treatment of respiratory insufficiency.
    Brouet G; Ruff F
    Minerva Med; 1976 Mar; 67(15):926-9. PubMed ID: 4749
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of theophylline in treatment of chronic obstructive pulmonary disease].
    Barg W; Kraus-Filarska M
    Pneumonol Alergol Pol; 1997; 65 Suppl 1():71-6. PubMed ID: 9410306
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of obstructive respiratory disorders using a new theophylline retard preparation].
    Schroers M; Merbach W; Don M
    ZFA (Stuttgart); 1982 Jun; 58(17):974-8. PubMed ID: 7113392
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of benzoctamine (Tacitin) on pulmonary ventilation in patients with respiratory insufficiency].
    Schaanning J; Frey J
    Tidsskr Nor Laegeforen; 1975 Aug; 95(24):1351-2. PubMed ID: 1101438
    [No Abstract]   [Full Text] [Related]  

  • 39. Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway disease.
    Cooper CB; Davidson AC; Cameron IR
    Bull Eur Physiopathol Respir; 1987; 23(1):15-22. PubMed ID: 3297214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Staged therapy of chronic obstructive respiratory tract diseases. Treatment of chronic obstructive respiratory tract diseases by the established physician].
    Hausen T
    Fortschr Med; 1989 Mar; 107(9):210-3. PubMed ID: 2566567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.